Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
BackgroundPleural mesothelioma (MPM) is an aggressive malignancy with an average patient survival of only 10 months. Interestingly, about 5%–10% of the patients survive remarkably longer. Prior studies have suggested that the tumor immune microenvironment (TIME) has potential prognostic value in MPM...
Main Authors: | Hely Ollila, Mikko I. Mäyränpää, Lassi Paavolainen, Juuso Paajanen, Katja Välimäki, Eva Sutinen, Henrik Wolff, Jari Räsänen, Olli Kallioniemi, Marjukka Myllärniemi, Ilkka Ilonen, Teijo Pellinen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.870352/full |
Similar Items
-
Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
by: Tommi Järvinen, et al.
Published: (2021-07-01) -
KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
by: Maria Hollmén, et al.
Published: (2023-09-01) -
Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine.
by: Katri Koli, et al.
Published: (2016-01-01) -
The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma
by: Juuso Paajanen, et al.
Published: (2022-11-01) -
Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
by: Jaana Kaunisto, et al.
Published: (2023-09-01)